R&D Delivery: The key to navigating pharmacy deserts in 2025 Pharmacy closures are accelerating fast.
Partner Content Partner Content ProQR Therapeutics presenting keynote at Oligonucleotide The... ProQR Therapeutics presents keynote at Oligonucleotide
Partner Content Partner Content ProQR Therapeutics presenting keynote at Oligonucleotide The... ProQR Therapeutics presents keynote at Oligonucleotide
Partner Content Partner Content Workshop Overview for Oligonucleotide Therapeutics and Deliv... Workshop Overview for Oligonucleotide Therapeutics
Partner Content Partner Content Registration is now open for Oligonucleotide Therapeutics an... Oligonucleotide Therapeutics Delivery 2020
Partner Content Partner Content Q&A with Team Consulting Ltd released for Injectable Drug De... Q&A with Team Consulting released for Injectable Drug
R&D Modelling biologics: Challenges and opportunities, with Dr D... From AAPS 2025, an interview with Dr Dhaval Shah, professor of pharmaceutical sciences at the University of Buffalo and former Pfizer researcher.
Market Access Sponsored Bridging research and clinical guidelines – interactive stra... Medical affairs is evolving. Understanding how to harness real-world data and digital insights is essential.
